Professional Documents
Culture Documents
Yunpeng Cheng,1 Yanqiu Zhu,2 Jiashu Zhang,3 Xingping Duan,3 Ying Zhang1
Department of Cardiology - the First Affiliated Hospital of Dalian Medical University;1 Department of Ultrasonics - Affiliated Zhongshan
Hospital of Dalian University;2 College of Pharmacy - Dalian Medical University3 China
Resumo
Fundamentos: A hiperlipidemia, que se caracteriza por uma elevao dos lipdeos na corrente sangunea, um
importante fator de risco para a doena cardaca.
Objetivos: O presente estudo investigou o papel da fibrose na progresso da hiperlipidemia no corao do rato e se a
ativao dos mastcitos estava associada ao processo de fibrose.
Mtodo: A hiperlipidemia foi produzida em ratos C57BL/6 alimentando-os com uma dieta rica em gordura durante 8
semanas. Para avaliar a fibrose tecidual, foi realizada colorao vermelha picro-Sirius. A colorao com hematoxilina e
eosina (H & E) foi feita para identificar as alteraes histopatolgicas nos coraes. A imuno-histoqumica tambm foi
levada a cabo para determinar a localizao do fator de crescimento transformante (TGF) - e -actina do msculo liso
(-SMA). O Western Blot foi realizado para analisar as expresses de quimase, triptase, TGF-, -SMA e a atividade da
via Wnt / -catenina. Finalmente, se mediram os nveis sricos de colesterol total (TC) e triglicerdeos (TG). Todos os
valores foram expressos como mdia DP, o nvel de significncia estatstica adotado foi de 5%.
Resultados: Os ratos hiperlipidmicos mostraram aumento significativo da deposio de colgeno nos coraes em
comparao com ratos normais. Alm disso, a colorao de H & E mostrou degenerao celular significativa. O msculo
cardaco estava em desordem com ruptura de fibras em ratos do grupo modelo. A anlise imuno-histoqumica e o Western
Blot revelaram que os nveis de expresso de triptase, quimase, -catenina, TGF- e -SMA estavam significativamente
aumentados nos ratos hiperlipidmicos em comparao com o grupo controle.
Concluses: Os resultados indicaram que a ativao de mastcitos pode induzir fibrose cardaca por triptase e quimase
em hiperlipidemia, a qual teve uma relao estreita com a atividade aumentada da via TGF- / Wnt / -catenina.
(Arq Bras Cardiol. 2017; [online].ahead print, PP.0-0)
Palavras-chave: Ratos, Hioperlipidemias / fisiopatologia, Corao, Fibrose, Leucemia de Mastcitos.
Abstract
Background: Hyperlipidemia, which is characterized by an elevation of lipids in the bloodstream, is a major risk factor for
cardiac disease.
Objectives: The present study investigated the role of fibrosis in the progression of hyperlipidemia in the mice heart, and
whether mast cell activation was associated with the fibrosis process.
Methods: Hyperlipidemia was produced in C57BL / 6 mice by feeding them on a high-fat diet for 8 weeks.To assess tissue fibrosis,
picrosirius red staining was performed. Hematoxylin & eosin (H&E) staining was performed to identify the histopathological
changes in the hearts. Immunohistochemistry was also accomplished to determine the localization of transforming growth factor
(TGF)- and -smooth muscle actin (-SMA). Western blotting was performed to analyze the expression of chymase, tryptase,
TGF-, -SMA and activity of Wnt/-catenin pathway. At the end, serum total cholesterol (TC) and triglycerides (TG) levels were
measured. All the values were expressed as means SD, the statistical significance level adopted was 5%.
Results: Hyperlipidemia mice showed significantly increased collagen deposition in the hearts compared with normal mice. In
addition, H&E staining showed significant cellular degeneration. Cardiac muscle was arranged in disorder with fracture in mice
of the model group. Immunohistochemistry and western blot analysis revealed that expression levels of tryptase, chymase,
-catenin, TGF- and -SMA were significantly increased in the hyperlipidemia mice compared with the control group.
Conclusions: The results indicated that mast cell activation might induce cardiac fibrosis by tryptase and chymase in
hyperlipidemia, which had a close relationship with the increased activity of TGF-/Wnt/-catenin pathway. (Arq Bras Cardiol.
2017; [online].ahead print, PP.0-0)
Keywords: Rats; Hyperlipidemias / physiopathology; Heart; Fibrosis; Leukemia, Mast-Cell.
Full texts in English - http://www.arquivosonline.com.br
Correspondncia: Ying Zhang
116044, Dalian, Liaoning China
E-mail: zhangying_xn@163.com
Artigo recebido em 14/02/2017, revisado em 25/05/2017, aceito em 03/07/2017
DOI: 10.5935/abc.20170143
Cheng et al
Fibrose cardaca induzida por hyperlipidemia
Tabela 1 Nveis sricos de TC e TG aps dieta rica em gordura durante 8 semanas. (mmol/l)
Grupo TG TC
Controle 0,73 0,12 1,87 0,25
H-lpido 1,21 0,13 3,34 0,33
Valor de p < 0,05 < 0,05
TC: colesterol total; TG: triglicerdeos.
Figura 1 Mudana em microfotografias cardacas de ratos hiperlipidmicos. Os coraes foram corados com H & E (A-B). Sees representativas dos coraes de
um rato de controle (A), rato hiperlipidmico (B). H & E, ampliao 400.
Quimase
TGF-
-catenina
-SMA
-actina
Figura 2 Efeito da hiperlipidemia na expresso proteica da triptase, da quimase, do TGF-, da -catenina e da -SMA nos coraes dos ratos hiperlipidmicos.
O grfico de barras mostra a relao de expresso relativa de cada protena calculada aps a normalizao por -actina. Os dados so expressos como mdia SD.
(*p<0,05 versus grupo controle; n = 8).
Figura 3 Efeito da hiperlipidemia na expresso proteica de TGF- nos coraes dos ratos hiperlipidmicos. Os coraes foram imunohistoqumicamente corados
(A-B). Sees representativas dos coraes de um rato de controle (A), um rato hiperlipidmico (B). Colorao imuno-histoqumica, ampliao 400.
Figura 4 Efeito da hiperlipidemia na acumulao de colgeno nos coraes dos ratos hiperlipidmicos. Os coraes foram corados com picro-Sirius vermelho (A-B).
Sees representativas dos coraes de um rato de controle (A), rato hiperlipidmico (B). Picro-Sirius colorao vermelha, ampliao 400.
Figura 5 Efeito da hiperlipidemia na expresso proteica de -SMA em coraes de ratos hiperlipidmicos. Os coraes foram imunohistoquimicamente corados (A-C).
Sees representativas dos coraes de um rato de controle (A), rato hiperlipidmico (B). Colorao imuno-histoqumica, ampliao 400.
de Western blot mostraram que as expresses proteicas de deste estudo demonstraram que os mastcitos e a via
triptase e de quimase no corao de ratos do grupo H-lipdico TGF- / Wnt / -catenina no eram apenas muito importantes
estavam aumentadas em comparao com o grupo controle. para a fibrose do tecido cardaco na hiperlipidemia, mas
Para explorar ainda mais o mecanismo molecular da fibrose tambm um possvel alvo para a terapia.
cardaca em ratos de hiperlipidemia, utilizando anlise
Western Blot e colorao imuno-histoqumica, examinamos
as expresses proteicas de TGF- que esto intrincadamente Contribuio dos autores
ligadas aos efeitos profibrticos dos mastcitos e a via Concepo e desenho da pesquisa e Redao do manuscrito:
Wnt / -catenina que essencial para a fibrose induzida por Cheng Y; Obteno de dados, Anlise e interpretao dos
TGF-. Os resultados da anlise Western Blot e da colorao dados e Anlise estatstica: Cheng Y, Zhu Y, Zhang J, Duan X;
imunohistoqumica demonstraram que as expresses Reviso crtica do manuscrito quanto ao contedo intelectual
proteicas de TGF- no corao do grupo de ratos H-lpidos importante: Cheng Y, Zhu Y.
aumentaram significativamente em comparao com o grupo
controle. Alm disso, os resultados da anlise Western Blot
mostraram que o nvel de expresso de protena alterada de Potencial conflito de interesses
-catenina era semelhante ao TGF-. Declaro no haver conflito de interesses pertinentes.
Referncias
1. Thinn Hlaing T, Park A. Hyperlipidemia. Medicine. 2013;41(10):607-9. myocarditis. Eur Heart J. 2017;38(18):1413-25. doi: 10.1093/eurheartj/ehw116.
2. Ansell, Benjamin J. Current world literature: hyperlipidaemia and 12. Madjene LC, Pons M, Danelli L, Claver J, Ali L, Madera-Salcedo IK, et al. Mast
cardiovascular disease. Curr Opin Lipidol. 2013;24(4):357-62. doi: cells in renal inflammation and fibrosis: lessons learnt from animal studies.
10.1097/MOL.0b013e328363a73b. Mol Immunol. 2015;63(1):86-93. doi: 10.1016/j.molimm.2014.03.002.
3. Peter R, Bajwa H, Anthony S. Hyperlipidemia and cardiovascular disease 13. Silver RB. Role of mast cells in renal fibrosis. Kidney Int. 2013;84(1):214.
- newer antihyperglycaemic agents and cardiovascular disease. Curr Opin doi: 10.1038/ki.2013.72.
Lipidol. 2013;24(2):189-90. doi: 10.1097/MOL.0b013e32835ec5f5.
14. Summers SA, Gan PY, Dewage L, Ma FT, Ooi JD, OSullivan KM, et al. Mast cell
4. Adebiyi OA, Adebiyi OO, Owira PM. Naringin reduces hyperglycemia- activation and degranulation promotes renal fibrosis in experimental unilateral
induced cardiac fibrosis by relieving oxidative stress. PLoS One. ureteric obstruction. Kidney Int. 2012;82(6):676-85. doi: 10.1038/ki.2012.211.
2016;11(3):e0149890. doi: 10.1371/journal.pone.0149890.
15. Gaca MD, Arthur MJ, Benyon RC. Mast cell protease and stem cell
5. Russo I, Frangogiannis NG. Diabetes-associated cardiac fibrosis: cellular factor expression in rat liver fibrosis. J Hepatol. 1998;28(Suppl):81. doi:
effectors, molecular mechanisms and therapeutic opportunities. J Mol Cell 10.1016/50168-8278(98)80523-0.
Cardiol. 2016;90:84-93. doi: 10.1016/j.yjmcc.2015.12.011.
16. Yadav A, Desai RS, Bhuta BA, Singh JS, Mehta R, Nehete AP. Altered
6. Fan D, Takawale A, Lee J, Kassiri Z. Cardiac fibroblasts, fibrosis and immunohistochemical expression of mast cell tryptase and chymase in the
extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair. pathogenesis of oral submucous fibrosis and malignant transformation of the
2012;5(1):15. doi: 10.1186/1755-1536-5-15. overlying epithelium. Plos One. 2014;9(5):e98719. doi: 10.1371/journal.
pone.0098719.
7. Kania G, Blyszczuk P, Eriksson U. Mechanisms of cardiac fibrosis in
inflammatory heart disease. Trends Cardiovasc Med. 2009;19(8):247-52. 17. Soehnlein O, Drechsler M, Hristov M, Weber C. Functional alterations of
doi: 10.1016/j.tcm.2010.02.005. myeloid cell subsets in hyperlipidemia: relevance for atherosclerosis. J Mol Cell
Cardiol. 2009;13(11-12):4293-303. doi: 10.1111/j.1582-4934.2009.00965.x.
8. Chen D, Jarrell A, Guo C, Lang R, Atit R. Dermal -catenin activity in response
to epidermal Wnt ligands is required for fibroblast proliferation and hair follicle 18. Spinas E; Kritas SK; Saggini A; Mobili A; Caraffa A; Antinolfi P; Pantalone A, et al. Role
initiation. Development. 2012;139(8):1522-33. doi: 10.1242/dev.076463. of mast cells in atherosclerosis: a classical inflammatory disease. Int J Immunopathol
Pharmacol. 2014;27(4):517-21. doi: 10.1177/039463201402700407.
9. Zerr P, Palumbo-Zerr K, Huang J, Tomcik M, Sumova B, Distler O, et al. Sirt1
regulates canonical TGF-[beta] signalling to control fibroblast activation 19. Adeneye AA, Adeyemi OO, Agbaje EO. Anti-obesity and antihyperlipidaemic
and tissue fibrosis. Ann Rheum Dis. 2016;75(1):226-33. doi: 10.1136/ effect of Hunteria umbellata seed extract in experimental hyperlipidemia. J
annrheumdis-2014-205740. Ethnopharmacol. 2010;130(2):307-14. doi: 10.1016/j.jep.2010.05.009.
10. Wang S, Meng XM, Ng YY, Ma FY, Zhou S, Zhang Y, et al. TGF-/Smad3 20. Slack J, Nevin NC. Hyperlipidaemic xanthomatosis. I. Increased risk of death
signalling regulates the transition of bone marrow-derived macrophages from ischaemic heart disease in first degree relatives of 53 patients with
into myofibroblasts during tissue fibrosis. Oncotarget. 2016;7(8):8809-22. essential hyperlipidemia and xanthomatosis. J Med Genet. 1968;5(1):4-8.
doi: 10.18632/oncotarget.6604. PMID: 5653869.
11. Blyszczuk P, Mller-Edenborn B, Valenta T, Osto E, Stellato M, Behnke S, et al. 21. Liao PH, Kuo WW, Kuo CH, Yeh YL, Shen CY, Cheng YH, et al. Lactobacillus reuteri
Transforming growth factor--dependent Wnt secretion controls myofibroblast GMNL-263 reduces hyperlipidemia and the heart failure process in high-calorie
formation and myocardial fibrosis progression in experimental autoimmune diet-fed induced heart dysfunction in rats. J Funct Foods. 2016;20:226-35.